SCI-110 in the Treatment of Tourette Syndrome
SCI-110 in the Treatment of Tourette Syndrome
Not yet recruiting · NCT05126888 · Registry updated 2026-04-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| SCI-110 in the Treatment of Tourette Syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Tourette syndrome, basal ganglia disorder, brain disorder, central nervous system disorder, hereditary disease, inherited neurodegenerative disorder, movement disorder, nervous system disorder, neurodegenerative disease, neurodevelopmental disorder, psychiatric disorder, tic disorder | Not yet recruiting | Phase 2 | 2026-04-21 | NCT05126888 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Neurothera Labs Inc. | 2 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Medizinische Hochschule Hannover | Hanover | Germany | 90 |
| Neurological Institute, Tel Aviv Sourasky Medical Center | Tel Aviv | Israel | 1 |
| Yale Child Study Center - NIHB 205 | New Haven | United States | 1 |